• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前放化疗后直肠癌的病理特征

Pathological features of rectal cancer after preoperative radiochemotherapy.

作者信息

Dworak O, Keilholz L, Hoffmann A

机构信息

Abteilung für Pathologie in der Chirurgischen Klinik, Erlangen, Germany.

出版信息

Int J Colorectal Dis. 1997;12(1):19-23. doi: 10.1007/s003840050072.

DOI:10.1007/s003840050072
PMID:9112145
Abstract

The standard therapy for rectal carcinoma is surgical, however, preoperative radiochemotherapy will play an increasing role especially in locally advanced disease. To estimate the prognosis and the effect of radiochemotherapy the postradiochemotherapeutical pathological features are important to assess. We examined the surgical specimens of 17 patients after preoperative radiochemotherapy to estimate and grade the histological reactions. A proposal for a grading system for tumor regression (not yet available in the literature) has also been described. All but one of the carcinomas showed different degrees of tumor regression. A total regression was not observed after standardised pathological work up. In only one case a locally curative resection was not possible. We think that preoperative radiochemotherapy is able to reduce tumor mass thus achieving operability in non-curatively operable cases. We recommend standards of pathological work up and regression grading for further studies comparing surgery and radiochemotherapy of rectal carcinoma.

摘要

直肠癌的标准治疗方法是手术,但术前放化疗在局部晚期疾病中发挥着越来越重要的作用。为了评估预后和放化疗效果,放化疗后的病理特征对于评估很重要。我们检查了17例术前放化疗患者的手术标本,以评估和分级组织学反应。还描述了一种肿瘤消退分级系统的建议(文献中尚未有)。除1例之外,所有癌均显示出不同程度的肿瘤消退。经过标准化病理检查后未观察到完全消退。仅1例无法进行局部根治性切除。我们认为术前放化疗能够减少肿瘤体积,从而在无法进行根治性手术的病例中实现可手术性。我们建议制定病理检查和消退分级标准,以用于进一步比较直肠癌手术和放化疗的研究。

相似文献

1
Pathological features of rectal cancer after preoperative radiochemotherapy.术前放化疗后直肠癌的病理特征
Int J Colorectal Dis. 1997;12(1):19-23. doi: 10.1007/s003840050072.
2
[Preoperative diagnostic procedures in locally advanced rectal carcinoma (> or =T3 or N+). What does endoluminal ultrasound achieve at staging and restaging (after neoadjuvant radiochemotherapy) in contrast to computed tomography?].[局部进展期直肠癌(≥T3 或 N+)的术前诊断程序。与计算机断层扫描相比,腔内超声在分期及新辅助放化疗后的再分期中能达到什么效果?]
Chirurg. 2003 Mar;74(3):224-34. doi: 10.1007/s00104-002-0609-z.
3
Accuracy of endorectal ultrasound after preoperative radiochemotherapy in locally advanced rectal cancer.术前放化疗后腔内超声在局部晚期直肠癌中的准确性
Surg Endosc. 1999 Oct;13(10):980-4. doi: 10.1007/s004649901151.
4
Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer.术前放化疗对直肠癌切除术后淋巴结清扫的影响。
Arch Surg. 2002 Feb;137(2):206-10. doi: 10.1001/archsurg.137.2.206.
5
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.术前放化疗后肿瘤退缩对直肠癌的预后意义。
J Clin Oncol. 2005 Dec 1;23(34):8688-96. doi: 10.1200/JCO.2005.02.1329. Epub 2005 Oct 24.
6
[Adjuvant and neoadjuvant therapy of rectal carcinoma. The current status].[直肠癌的辅助和新辅助治疗。现状]
Strahlenther Onkol. 1998 Oct;174(10):497-504. doi: 10.1007/BF03038981.
7
[Proliferation and apoptosis before and after preoperative simultaneous radiochemotherapy of rectal carcinomas].直肠癌术前同步放化疗前后的增殖与凋亡
Strahlenther Onkol. 1998 Jun;174(6):295-9. doi: 10.1007/BF03038542.
8
[Efficacy assessment of preoperative radiochemotherapy and analysis of associated factors in rectal cancer].
Zhonghua Wei Chang Wai Ke Za Zhi. 2008 May;11(3):238-40.
9
High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection.高生存素表达与直肠癌细胞凋亡减少相关,且可能预测术前放化疗及手术切除后的无病生存期。
Strahlenther Onkol. 2002 Aug;178(8):426-35. doi: 10.1007/s00066-002-1003-y.
10
Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94).局部晚期直肠癌辅助性与新辅助放化疗对比:一项III期随机试验(CAO/ARO/AIO-94方案)的进展报告
Strahlenther Onkol. 2001 Apr;177(4):173-81. doi: 10.1007/pl00002396.

引用本文的文献

1
Dual Immune Checkpoint Inhibition Plus Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Randomized Clinical Trial.双重免疫检查点抑制联合新辅助放化疗治疗直肠癌:一项随机临床试验
JAMA Netw Open. 2025 Aug 1;8(8):e2527769. doi: 10.1001/jamanetworkopen.2025.27769.
2
Early prediction of histopathological response of locally advanced rectal cancer after 1 week of preoperative radiochemotherapy using FDG PET-CT imaging: a prospective clinical validation study.使用氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描(FDG PET-CT)成像对局部晚期直肠癌术前放化疗1周后组织病理学反应进行早期预测:一项前瞻性临床验证研究。
Radiat Oncol. 2025 Aug 1;20(1):121. doi: 10.1186/s13014-025-02703-x.
3
Predicting neoadjuvant chemoradiotherapy response in rectal cancer: Insights from biomarkers to clinical practice.
预测直肠癌新辅助放化疗反应:从生物标志物到临床实践的见解
World J Gastrointest Surg. 2025 Jul 27;17(7):106724. doi: 10.4240/wjgs.v17.i7.106724.
4
Radiotherapy boost to the primary tumour in locally advanced rectal cancer: Systematic review of practices and -analysis.局部晚期直肠癌原发肿瘤的放疗增敏:实践系统评价与分析
Clin Transl Radiat Oncol. 2025 Jul 13;54:101014. doi: 10.1016/j.ctro.2025.101014. eCollection 2025 Sep.
5
CD133 and CD166 Stem Cells Markers Expression, Clinicopathological Parameters, and Fragmentation Response Patterns of ypT3 Rectal Cancer Following Neoadjuvant Chemoradiotherapy.新辅助放化疗后ypT3期直肠癌的CD133和CD166干细胞标志物表达、临床病理参数及分割反应模式
Biomedicines. 2025 May 26;13(6):1300. doi: 10.3390/biomedicines13061300.
6
Predictive Value of Tumor Regression Grading on the Prognosis of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Systematic Review and Meta-Analysis.肿瘤退缩分级对局部进展期胃癌新辅助化疗预后的预测价值:一项系统评价和Meta分析
Clin Transl Gastroenterol. 2025 May 14;16(7):e00860. doi: 10.14309/ctg.0000000000000860. eCollection 2025 Jul 1.
7
Lateral Pelvic Recurrence in Rectal Cancer Is Not Local Recurrence but Lymphatic Metastasis.直肠癌的侧方盆腔复发并非局部复发,而是淋巴转移。
J Anus Rectum Colon. 2025 Apr 25;9(2):225-236. doi: 10.23922/jarc.2024-102. eCollection 2025.
8
The tumour-stroma ratio as predictive aid towards a biopsy-based treatment strategy in rectal carcinoma.肿瘤-间质比作为直肠癌基于活检的治疗策略的预测辅助指标。
Histopathology. 2025 Jul;87(1):44-57. doi: 10.1111/his.15423. Epub 2025 Apr 4.
9
Clinical Prediction Models for Contact X-Ray Brachytherapy in Managing Rectal Cancers: A Scoping Review.用于直肠癌治疗中接触性X射线近距离放射治疗的临床预测模型:一项范围综述
Cancer Med. 2025 Apr;14(7):e70697. doi: 10.1002/cam4.70697.
10
Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trial.CAO/ARO/AIO-04随机3期试验中局部晚期直肠癌患者腹会阴切除术后的预后及生活质量
Sci Rep. 2025 Feb 13;15(1):5401. doi: 10.1038/s41598-024-83105-z.